
Our appreciation in Diabetologia of Steve Ashcroft who sadly passed away in November. Steve made fundamental contributions to our understanding of beta cell glucose sensing including the substrate site hypothesis and the role of KATP channels.

Professor of Medicine Université de Montréal, Imperial College London, Nanyang Technological University Singapore. Wellcome Investigator.

Our appreciation in Diabetologia of Steve Ashcroft who sadly passed away in November. Steve made fundamental contributions to our understanding of beta cell glucose sensing including the substrate site hypothesis and the role of KATP channels.

📢 #CIHR, #NSERC and #SSHRC are proud to launch the new Canada Impact+ Research Training Awards to support the recruitment of international doctoral students and postdoctoral researchers to Canada. Learn more about this new initiative: ▶️ tinyurl.com/yc54p4da

📢Today, the #GC launched new programs to attract international researchers to Canada. ✅ Canada Impact+ Research Chairs ✅ Canada Impact+ Emerging Leaders Get all the details here: canada.ca/en/impact-plus-cha… @SSHRC_CRSH @NSERC_CRSNG @CIHR_IRSC @InnovationCA @ISED_CA

Leveraging the inhibition of disallowed beta cell genes as a therapeutic strategy!
LDHA inhibition could be a novel therapeutic strategy for #diabetes treatment link.springer.com/article/10… @DiabetologiaJnl

Canada’s new government is investing big to attract world-class talent in science and technology — and become an innovation powerhouse.

29%—That's a lot of weight loss, folks Triple GLP-1 drug receptor retatrutide Compares with avg weight loss with Zepbound 21%, Wegovy (Ozempic) 15% nytimes.com/2025/12/11/healt…

ER calcium stores contribute to glucose-induced Ca2 waves and interce... sciencedirect.com/science/ar… Revisiting an old question with new tools! @L_F_D_S #BillLouch @CRCHUM @CRCHUM_CELLS @wellcometrust @CIHR_IRSC @BT1D_CA

Impaired cAMP–PKA–CREB1 signalling drives mitochondrial dysfunction in skeletal muscle during cancer cachexia | Nature Metabolism nature.com/articles/s42255-0…

Out today in Diabetes! Additive Effects of Dorzagliatin and Glucagon-Like Peptide-1 Receptor Agonism in a Novel Mouse Model of GCK-MODY and in Obese db/db Mice | Diabetes | American Diabetes Association @CRCHUM @ImperialMDR diabetesjournals.org/diabete…

#Throwback REVIEW | @guy_rutter , @BennyScience et al Exploring pancreatic beta-cell subgroups and their connectivity nature.com/articles/s42255-0…

Relaunching our @CRCHUM Cardiometabolic Axis data sessions data sessions today with amazing talks from #mathiasguayasamin and #luisdelgadillosilva. #ciaranmurphyroyal @CRCHUM_CELLS

Not one, but TWO endocrinologists to join the Canadian Medical Hall of Fame in 2026. Both Drs Hegele and Zinman have changed the way we treat metabolic disorders forever. In addition though … they are just kind humans. Congratulations!!🎉🎊🎈
Join us in congratulating the #2026CMHFInductees!cdnmedhall.ca/induction PAVEL HAMET, MD PhD ROBERT ALEXANDER HEGELE, MD MICHAEL D. HILL, MD MARY R. L'ABBÉ, PhD MORAG PARK, PhD BERNARD ZINMAN, MDCM @kellygrant1 @Megan_Ogilvie @LaurenPelley @DubinskiKa4985 @JenLeeCBC @Avis_Favaro

Important new review from my @CRCHUM colleague #MarcDonath
Inflammation is a key driver of the pathophysiology of cardiometabolic disorders #obesity #T2D and new metabolic medicines based on GLP-1 action exert their magic in part by reducing inflammation. A new review from Professor Donath summarizes the field sciencedirect.com/science/ar…

I‑BET151 modulates glucokinase gene expression and beta cellfunction in part through changes in FOXO1 expression rdcu.be/eIBCo Assoc. Prof Yusuf Ali's team @NTU_LKCMedicine in collaboration with @guy_rutter and @astar_research discovered that BET protein inhibition (I-BET151) impacts pancreatic β-cell function. 🔹 ↑ Glucose excursions 🔹 ↓ Insulin response 🔹 Downregulation of MODY genes (Hnf4α, Gck, Hnf1α, Glut2) & PI3K–Akt pathway ⚠️ BET therapies may impair β-cell health — caution warranted. #Diabetes #Epigenetics #BETinhibition

All true. But the same rigour should be applied to ALL the antibodies we use. Those against glucokinase are a case in point.
In some of these papers, glp1r detection is a small element. In others it's a large element. Don't trust antibody vendors, and do the legwork. As a field we are always happy to provide reagents/models to help with validation.

Our new report with #YaChiHuang #MarjanRupnik using high-speed imaging in pancreatic slices. Pancreatic α-cells are functionally heterogeneous and sex-dependently regulated by neighboring endocrine cells | bioRxiv biorxiv.org/content/10.1101/…